Medric Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.50 M
as on 14-12-2024
- Revenue 756.92%
(FY 2023)
- Profit 119.54%
(FY 2023)
- Ebitda 155.98%
(FY 2023)
- Net Worth 23.17%
(FY 2023)
- Total Assets 85.66%
(FY 2023)
About Medric Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mitali Singh and Ritu Rani serve as directors at the Company.
- CIN/LLPIN
U52609HR2021PTC092625
- Company No.
092625
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medric Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mitali Singh  | Director | 02-Feb-2021 | Current |
| Ritu Rani | Director | 03-Jun-2021 | Current |
Financial Performance of Medric Pharma.
Medric Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 756.92% increase. The company also saw a substantial improvement in profitability, with a 119.54% increase in profit. The company's net worth Soared by an impressive increase of 23.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medric Pharma?
Unlock access to Medric Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Feb 2022 | ₹0.50 M | Satisfied |
How Many Employees Work at Medric Pharma?
Medric Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medric Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medric Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
